Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
---|
11/22/2006 | CN1285572C Cannabinod receptor ligands |
11/21/2006 | US7138533 acetylcholinesterase inhibitory action and an alpha 1 antagonistic action |
11/21/2006 | US7138432 Arylsulfonamido-substituted hydroxamic acid derivatives |
11/21/2006 | US7138413 Administering tertiary amines, e.g., 3,3-Dimethylbutyl 3-piperidinopropyl ether, 3-Phenylpropyl 3-piperidinopropyl ether, or3-(4-Chlorophenyl)propyl 3-piperidinopropyl ether to treat cognitive disorders such as attention, wakefulness and memory disorders |
11/21/2006 | US7138412 For therapy of thromboembolic and/or inflammatory disorders |
11/21/2006 | US7138411 Substituted benzopyran derivatives for the treatment of inflammation |
11/21/2006 | US7138400 N-substituted with a methylene-bridged nonaromatic ring system, e.g., N-(2-(benzyloxy)-5,6,7,8,9,10-hexahydro-6,9-methanobenzo(a)(8)annulen-11-yl)-N'-(2,2,2-trifluoroethyl)-sulfamide; preventing or treating Alzheimer's Disease |
11/21/2006 | CA2334718C Quinoline derivatives |
11/21/2006 | CA2220080C Method for making quinolone carboxylic acids or naphthyridine carboxylic acids in free base form |
11/16/2006 | WO2006121095A1 Substituted acrylamide derivative and pharmaceutical composition comprising the same |
11/16/2006 | WO2006120573A2 Heterocyclic n-oxides as hypoxic selective protein kinase inhibitors |
11/16/2006 | WO2006120478A2 Quinoline derivatives as neurokinin receptor antagonists |
11/16/2006 | WO2006119713A2 Antineoplastic compounds and pharmaceutical compositions thereof |
11/16/2006 | WO2006088541A3 Quinoline derivatives and uses thereof |
11/16/2006 | WO2006060346A3 8-phenyl-5,6,7,8-hydroquinoline tachykinin receptor antagonists |
11/16/2006 | US20060258869 reacting 7-hydroxy-tetrahydroquinolinone with 1-bromo-4-chlorobutane in the presence of a base in a solvent; for treatment of Alzheimer's dementia, antipsychotic disorders and bipolar disorders |
11/16/2006 | US20060258868 Hepatitis c inhibitor peptide analogs |
11/16/2006 | US20060258859 Histamine receptor antagonists; 4-[3-(4-Piperidin-1-yl-but-1-ynyl)-benzyl]-thiomorpholine; antiallergens, antihistamines, antiepileptic agents; asthma, alzheimer's disease, narcolepsy, motion sickness, attention deficit disorder, schizophrenia |
11/16/2006 | US20060258723 Substituted Heteroaryl- and Phenylsulfamoyl Compounds |
11/16/2006 | US20060258677 Novel crystalline forms of gatifloxacin and processes for preparation |
11/16/2006 | US20060258676 Novel crystalline forms of gatifloxacin and processes for preparation |
11/16/2006 | US20060258675 Novel crystalline forms of gatofloxacin and processes for preparation |
11/16/2006 | US20060258674 Novel crystalline forms of gatifloxacin and processes for preparation |
11/16/2006 | US20060257613 Metal complexes as light-absorbing compounds in the information layer of optical data carriers |
11/16/2006 | CA2607874A1 Quinoline derivatives as neurokinin receptor antagonists |
11/16/2006 | CA2607298A1 Antineoplastic compounds and pharmaceutical compositions thereof |
11/15/2006 | EP1721898A1 Quinoline and pyridoquinoxaline derivatives as antibacterial agents |
11/15/2006 | EP1720870A1 Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments |
11/15/2006 | EP1720848A1 Derivatives of alkylpiperazine- and alkylhomopiperazine- carboxylates, preparation method thereof and use of same as faah enzyme inhibitors |
11/15/2006 | EP1720847A1 Histamine-3 receptor modulators |
11/15/2006 | EP1720829A1 Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors |
11/15/2006 | EP1720542A1 Arylalkylamino-substituted quinazoline analogues |
11/15/2006 | EP1670778B1 Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics |
11/15/2006 | EP1326610B1 Aza-and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors |
11/15/2006 | EP1007514B1 Heterocyclic ketones as npy y5 antagonists |
11/15/2006 | CN1863776A Crystalline form of gatifloxacin |
11/15/2006 | CN1863775A Substituted pentanols, a process for their production and their use as anti-inflammatory agents |
11/15/2006 | CN1863774A Compounds and compositions as protein kinase inhibitors |
11/15/2006 | CN1284771C TNF-α生成抑制剂 TNF-α production inhibitor |
11/14/2006 | US7135570 Selective hydrogenation of amino-substituted fused bicyclic aromatic ring system, preparation of racemic amino substituted fused bicyclic ring system via nitrosation, enzymatic resolution of racemic mixture to produce (R)- and (S)-forms |
11/14/2006 | US7135567 Processes for producing 2,4,6-tris(hydroxyphenyl amino)-1,3,5-triazines and 2,4,6-tris(substituted phenylamino)-1,3,5-triazines |
11/14/2006 | US7135483 Substituted heterocyclic compounds for treating multidrug resistance |
11/14/2006 | US7135473 Cyclic diamine compound with condensed-ring groups |
11/14/2006 | US7135466 used in the treatment of diseases mediated by the autophosphorylation of a PDGF receptor, specifically, compounds which can inhibit neointima formation hypertrophy. |
11/14/2006 | CA2111386C Substituted benzoylguanidines, process for their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical containing them |
11/09/2006 | WO2006118169A1 Antiasthmatic drug comprising pgd2 receptor antagonist and leukotriene receptor antagonist |
11/09/2006 | WO2006117977A1 Process for production of carbostyril compound |
11/09/2006 | WO2006117570A1 Quinoline derivatives as kinase enzyme inhibitors |
11/09/2006 | WO2006117552A1 Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity |
11/09/2006 | WO2006117371A1 4-PHENYL-5-0X0-l,4,5,6,7,8-HEXAHYDR0QËIN0LINE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF INFERTILITY |
11/09/2006 | WO2006117370A1 4-PHENYL-5-OXO-l,4,5,6,7,8-HEXAHYDROQUINOLINE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF INFERTILITY |
11/09/2006 | WO2006117368A1 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives the treatment of infertility |
11/09/2006 | WO2006117023A1 Dihydropyridine derivatives |
11/09/2006 | WO2006060344A3 5-phenyl-5,6,7,8-hydroquinoline tachykinin receptor antagonists |
11/09/2006 | WO2006028963A3 Substituted heterocyclic compounds and uses thereof |
11/09/2006 | US20060252813 Apparatus for curing a composite laminate |
11/09/2006 | US20060252795 Chemokine receptor binding heterocyclic compounds |
11/09/2006 | US20060252794 Process for preparing 5-'(r)-2-(5,6-diethyl-indian-2-ylamino)-1-hydroxy-ethyl!-8-hydroxy-(1h)-quinolin-2-one salt, useful as an andrenoceptor agonist |
11/09/2006 | US20060252778 Compounds for the treatment of inflammatory disorders |
11/09/2006 | US20060252772 Novel crystalline forms of gatifloxacin and processes for preparation |
11/09/2006 | US20060252771 Novel crystalline forms of gatifloxacin and processes for preparation |
11/09/2006 | US20060252770 Novel crystalline forms of gatifloxacin and processes for preparation |
11/09/2006 | CA2607106A1 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility |
11/09/2006 | CA2606683A1 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility |
11/09/2006 | CA2606682A1 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility |
11/09/2006 | CA2606338A1 Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity |
11/08/2006 | EP1718646A1 1,2,4-triazolo[4,3-a]pyridines useful in the treatment of gastrointestinal disorders |
11/08/2006 | EP1718615A1 Novel quinoline-carbaxamides as jack3 kinase modulators |
11/08/2006 | EP1718604A1 Immunosuppressant compounds and compositions |
11/08/2006 | EP1080074B1 Heterocyclic substituted amides, their production and their use |
11/08/2006 | EP1021190B1 Amid derivatives as growth hormone release promotors |
11/08/2006 | CN1283635C Heterocyclic retinoid compounds |
11/08/2006 | CN1283628C 8- hydroxy quinoline bryhtening blue light and preparation method |
11/07/2006 | US7132681 Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds |
11/07/2006 | US7132576 Rearrangement of allyl alcohols, especially production of linalool from geraniol or nerol; various isomerization catalysts may be used including dioxotungsten(VI) complexes containing 8-hydroxyquinoline ligands |
11/07/2006 | US7132547 Preventives/remedies for urinary disturbance |
11/07/2006 | US7132542 Compounds for the treatment of male erectile dysfunction |
11/07/2006 | US7132537 Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states |
11/07/2006 | US7132431 Anti-malarial compounds |
11/07/2006 | US7132426 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
11/07/2006 | US7132422 An aromatic-oxy-alkyleneamine derivative, useful for treating neuropathic pain |
11/07/2006 | US7132420 Aspartic protease inhibitors |
11/07/2006 | CA2130703C Diacyl-substituted guanidines, a process for their preparation, their use as medicine or diagnostic aid, and medicine containing them |
11/02/2006 | WO2006115652A1 Fluorinated pyridine n-oxide thrombin modulators and process for n-oxidation of nitrogen containing heteroaryls |
11/02/2006 | WO2006114260A1 Phenylacetylene derivatives having mglur5 receptor affinity |
11/02/2006 | WO2006097488A8 Use of n- (4-pyridyl) methylsulfonamides for combating arthropodal pests |
11/02/2006 | WO2006059149A8 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists |
11/02/2006 | US20060247439 Mchir antagonists |
11/02/2006 | US20060247272 4-Amino Substituted-2-Substituted-1,2,3,4-tetrahydroquinoline Compounds |
11/02/2006 | US20060247271 Sulphonyl hydroxamic acid derivatives as inhibitors of s-cd23 |
11/02/2006 | US20060247259 Urea derivatives containing aromatic or heteroaromatic rings; 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide; prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective |
11/02/2006 | US20060247229 Sulfonyl substituted n-(biarylmethyl) aminocyclopropanecarboxamides |
11/02/2006 | US20060247223 Non-imidazole alkylamines as histamine H3- receptor ligands and their therapeutic applications |
11/02/2006 | US20060247219 Specific glucocorticosteriod compound having anti-inflamatory activity |
11/02/2006 | US20060247217 Tricyclic protein kinase inhibitors |
11/02/2006 | US20060247212 Heterocyclic compounds having inhibitory activity against HIV integrase |
11/02/2006 | EP1717220A2 Vanilloid receptor ligands and their use in treatments |
11/02/2006 | EP1716851A1 Thioamides and salts thereof and cytokine production inhibitors containing both |
11/02/2006 | EP1716137A1 Substituted quinoline compounds |
11/02/2006 | EP1716134A1 Amino heterocyclic modulators of chemokine receptor activity |